Sandip Kumar Mitra, Naresh Kanumilli,
Maria Letizia Petroni, Jiten Vora,
Tirthankar Chaudhury, Atherosclerotic cardiovascular disease in metabolic syndrome, in: Metabolic Syndrome From Mechanisms to Interventions 1st Edition, London, Academic Press, 2023, pp. 249 - 258 [capitolo di libro]
Caviglia, GP; Armandi, A; D'Ambrosio, R; Lampertico, P; Bianco, C; Valenti, L; Ciccioli, C; Pennisi, G; Petta, S; Brodosi, L; Petroni, ML; Marchignoli, F; Pironi, L; Sagripanti, A; Argenziano, ME; Svegliati-Baroni, G; Bugianesi, E, Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interimanalysis of an Italian prospective multicentre study, «JOURNAL OF HEPATOLOGY», 2023, 78, pp. 673 - 674 [abstract]
Brodosi, L; Stecchi, M; Osti, V; Guarneri, V; Genovese, M; Marchignoli, F; Mita, D; Zioutas, M; Petroni, ML; Pironi, L, Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome, «JOURNAL OF HEPATOLOGY», 2023, 78, pp. 640 - 641 [abstract]
Bazzocchi, A; Gazzotti, S; Santarpia, L; Madeddu, C; Petroni, ML; Gómez, MPA, Editorial: Importance of body composition analysis in clinical nutrition, «FRONTIERS IN NUTRITION», 2023, 9, Article number: 1080636, pp. 01 - 04 [articolo]
Petroni M.L.; Brodosi L.; Armandi A.; Marchignoli F.; Bugianesi E.; Marchesini G., Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs, «NUTRIENTS», 2023, 15, Article number: 792, pp. 1 - 12 [articolo]Open Access
Tempia Valenta, Silvia; Stecchi, Michele; Perazza, Federica; Nuccitelli, Chiara; Villanova, Nicola; Pironi, Loris; Atti, Anna Rita; Petroni, Maria Letizia, Liraglutide 3.0 mg and mental health: can psychiatric symptoms be associated to adherence to therapy? Insights from a clinical audit, «EATING AND WEIGHT DISORDERS», 2023, 28, Article number: 99, pp. 1 - 10 [articolo]Open Access
Brodosi, Lucia; Petroni, Maria Letizia; Marchesini, Giulio, Looking ahead to potential incretin combination therapies for nonalcoholic steatohepatitis in patients with diabetes, «EXPERT OPINION ON PHARMACOTHERAPY», 2023, 24, pp. 989 - 1000 [articolo]
Tirthankar Chaudhury, Lucia Brodosi, Giulio Marchesini, Sandip Kumar Mitra, Maria Letizia Petroni, NAFLD, the hepatic manifestation of the metabolic syndrome, in: Metabolic Syndrome From Mechanisms to Interventions 1st Edition, London, Academic Press, 2023, pp. 279 - 291 [capitolo di libro]
Musio A.; Perazza F.; Leoni L.; Stefanini B.; Dajti E.; Menozzi R.; Petroni M.L.; Colecchia A.; Ravaioli F., Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2023, 24, Article number: 7517, pp. 1 - 37 [articolo]Open Access
Zhu, BH; Gostoli, S; Benasi, G; Patierno, C; Petroni, ML; Nuccitelli, C; Marchesini, G; Fava, GA; Rafanelli, C, Promoting weight loss and psychological well-being in patients with obesity: A sequential combination of behavioural lifestyle intervention and well-being therapy, «CLINICAL PSYCHOLOGY & PSYCHOTHERAPY», 2023, 30, pp. 422 - 435 [articolo]Open Access
Brodosi L.; Stecchi M.; Marchignoli F.; Lucia E.; Magnani L.; Guarneri V.; Petroni M.L.; Marchesini G.; Pironi L., Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease, «EATING AND WEIGHT DISORDERS», 2023, 28, Article number: 100, pp. 1 - 9 [articolo]Open Access
Petroni, Maria Letizia; Brodosi, Lucia; Marchesini, Giulio, The treatment of diabetes in advanced liver disease: change of a paradigm, «ANNALS OF HEPATOLOGY», 2023, 28, Article number: 100772, pp. 1 - 3 [articolo]Open Access
Baccolini, Luca; Centis, Elena; Malaguti, Anna; Forlani, Gabriele; Marchesini, Giulio; Petroni, Maria L, A psycho-educational intervention for the prevention of foot lesions in people with diabetes: Report of a clinical audit, «NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES», 2022, 32, pp. 2264 - 2272 [articolo]
Brodosi L.; Marchignoli F.; Marchesini G.; Petroni M.L., Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease, «EXPERT OPINION ON PHARMACOTHERAPY», 2022, 23, pp. 149 - 153 [articolo]
Caretto A., Pintus S., Petroni M.L., Osella A.R., Bonfiglio C., Morabito S., Zuliani P., Sturda A., Castronuovo M., Lagattolla V., Maghetti A., Lapini E., Bianco A.M., Cisternino M., Cerutti N., Mulas C.A., Hassan O., Cardamone N., Parillo M., Sonni L., Urso E., Bianco C., Scotto Di Carlo M., Fantola G., Vincis M., Pironi L., Barbanti F., Musio A., Ravaioli F., Minciullo F., Balzano R., Cozzolino A.R., Castanò I., Cusano P., Di Giacomo C., Mollica M.P., Coppola M., Della Rosa D., Vignola G., Bolesina L., Zaccheroni V., Pullara R., Caprino G., Tubili C., Baccari B., Monacelli G., Paolini B., Martinelli B., Carella M., Di Gregorio C., Cella D., Facci W., Lista M., Giungato S., Fazzolari L., Altomare M., Lo Prinzi L., Grandone I., Vigna L., Di Berardino P., Messeri L., Determinants of weight, psychological status, food contemplation and lifestyle changes in patients with obesity during the COVID-19 lockdown: a nationwide survey using multiple correspondence analysis, «INTERNATIONAL JOURNAL OF OBESITY», 2022, 46, pp. 1280 - 1287 [articolo]Open Access
